Ranbaxy share price target 2014
Ranbaxy stock short term technical view
Ranbaxy stock on last trading session closed at 443 with gain. On daily chart, stock price trend is bullish but momentum is weak as correction phase is going on. From short-term view, Ranbaxy stock has supports at 425 and 400 rupees. 425 is major average level and above it, short-term traders keep long view for stock. On upside 465 and 490 are strong resistance levels and targets zones if reversal happens. Daily chart indicators patterns are mixed suggest consolidation may continue ahead.
Traders here above 425 levels keep buy and accumulate view for short term targets 465 and then 490 which can expected in next 1 month period.
Ranbaxy stock medium term technical view
Ranbaxy stock on weekly chart is showing losses in this week. This will be straight forth-losing week for stock. From medium term view, stock price trend is bullish but momentum is bearish because of correction phase. On chart, 410-420 is major average support zone and above it, medium term investor’s should keep long view. On upside 505 and 585 are strong resistances as well as target zones for next 6 to 12 month period. On downside, 410 and then 334 are strong support levels. Weekly chart indicators pattern are bearish and reflecting market momentum towards stock.
Medium term traders and investors above 410 can follow buy and accumulate strategy for target 505 and above. Below 410, we may see panic sell of up to 334 rupees.
Ranbaxy stock long term technical view
Ranbaxy stock for month of May is showing loss on profit booking by investors. In last 6 months period stock has given only 4% returns to investors and wildly underperforming major indices. From long-term view, 400 rupee is crucial level to watch on monthly closing basis. On upside 590 and 755 rupee are strong resistances as well as target zones for next 12 to 36 months period. On downside 250-rupee best, buy zone, which was last seen in august 2013. While 100-140 rupees was much-undervalued zone, which was last seen in 2009. Investors above 400 keep long positions open for upside targets.
Ranbaxy company description
Ranbaxy Laboratories Limited is an integrated international pharmaceuticals company. The Company is engaged in the marketing, production and distribution of pharmaceutical products. The Company’s business activity falls within a single primary business segment viz. Pharmaceutical. The Company has ground operations in over 40 countries, products sold in over 150 countries, manufacturing facilities in approximately eight countries. The Company owns manufacturing facilities in seven countries, namely India, the United States of America, Ireland, Malaysia, Nigeria, Romania and South Africa. The Company’s markets include the United States of America, India, Europe, Russia/ CIS and South Africa. The research and development activities of the Company are principally carried out at its facilities in Gurgaon, near New Delhi, India.